These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37393721)

  • 1. Generation of two edited iPSCs lines by CRISPR/Cas9 with point mutations in PKP2 gene for arrhythmogenic cardiomyopathy in vitro modeling.
    Amin G; Castañeda SL; Zabalegui F; Belli C; Atorrasagasti C; Miriuka SG; Moro LN
    Stem Cell Res; 2023 Sep; 71():103157. PubMed ID: 37393721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM).
    Janz A; Zink M; Cirnu A; Hartleb A; Albrecht C; Rost S; Klopocki E; Günther K; Edenhofer F; Ergün S; Gerull B
    Stem Cell Res; 2021 May; 53():102256. PubMed ID: 33640690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of iPSC line from patient with arrhythmogenic right ventricular cardiomyopathy carrying mutations in PKP2 gene.
    Khudiakov A; Kostina D; Zlotina A; Yany N; Sergushichev A; Pervunina T; Tomilin A; Kostareva A; Malashicheva A
    Stem Cell Res; 2017 Oct; 24():85-88. PubMed ID: 29034900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a CRISPR/Cas9-edited Plakoglobin (JUP) knock-out (JMUi001-A-4) iPSC line to model the cardiac phenotype of arrhythmogenic cardiomyopathy.
    Walz K; Janz A; Klopocki E; Gerull B
    Stem Cell Res; 2023 Dec; 73():103240. PubMed ID: 37995437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50.
    Ermon B; Volpato CB; Cattelan G; Silipigni R; Di Segni M; Cantaloni C; Casella M; Pramstaller PP; Pompilio G; Sommariva E; Meraviglia V; Rossini A
    Stem Cell Res; 2018 Oct; 32():78-82. PubMed ID: 30219716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of human induced pluripotent stem cell line LUMCi027-A and its isogenic gene-corrected line from a patient affected by arrhythmogenic cardiomyopathy and carrying the c.2013delC PKP2 mutation.
    Meraviglia V; Arendzen CH; Tok M; Freund C; Maione AS; Sommariva E; Bellin M
    Stem Cell Res; 2020 Jul; 46():101835. PubMed ID: 32485643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of CRISPR/Cas9 edited human induced pluripotent stem cell line carrying the heterozygous p.H695VfsX5 frameshift mutation in the exon 10 of the PKP2 gene.
    Pierre B; Laëtitia DB; Camille B; Claire P; Elise B; Estelle G; Vincent F; Eric V
    Stem Cell Res; 2024 Apr; 76():103341. PubMed ID: 38382214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYH10 activation rescues contractile defects in arrhythmogenic cardiomyopathy (ACM).
    García-Quintáns N; Sacristán S; Márquez-López C; Sánchez-Ramos C; Martinez-de-Benito F; Siniscalco D; González-Guerra A; Camafeita E; Roche-Molina M; Lytvyn M; Morera D; Guillen MI; Sanguino MA; Sanz-Rosa D; Martín-Pérez D; Garcia R; Bernal JA
    Nat Commun; 2023 Oct; 14(1):6461. PubMed ID: 37833253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Molecular Data Define a Diagnosis of Arrhythmogenic Cardiomyopathy in a Carrier of a Brugada-Syndrome-Associated
    Persampieri S; Pilato CA; Sommariva E; Maione AS; Stadiotti I; Ranalletta A; Torchio M; Dello Russo A; Basso C; Pompilio G; Tondo C; Casella M
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32443836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of human induced pluripotent stem cell line EURACi006-A and its isogenic gene-corrected line EURACi006-A-1 from an arrhythmogenic cardiomyopathy patient carrying the c.1643delG PKP2 mutation.
    Meraviglia V; Ganesh S; Arendzen CH; Freund C; Sommariva E; Rossini A; Bellin M
    Stem Cell Res; 2021 Jul; 54():102426. PubMed ID: 34134068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive Reduction in Right Ventricular Contractile Function Attributable to Altered Actin Expression in an Aging Mouse Model of Arrhythmogenic Cardiomyopathy.
    Camors EM; Roth AH; Alef JR; Sullivan RD; Johnson JN; Purevjav E; Towbin JA
    Circulation; 2022 May; 145(21):1609-1624. PubMed ID: 35437032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.
    Kim C; Wong J; Wen J; Wang S; Wang C; Spiering S; Kan NG; Forcales S; Puri PL; Leone TC; Marine JE; Calkins H; Kelly DP; Judge DP; Chen HS
    Nature; 2013 Feb; 494(7435):105-10. PubMed ID: 23354045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of three TTN knock-out human induced pluripotent stem cell lines using CRISPR/Cas9 system.
    Kang JY; Mun D; Chun Y; Park DS; Kim H; Yun N; Lee SH; Joung B
    Stem Cell Res; 2022 Oct; 64():102901. PubMed ID: 36037555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular disturbance underlies to arrhythmogenic cardiomyopathy induced by transgene content, age and exercise in a truncated PKP2 mouse model.
    Moncayo-Arlandi J; Guasch E; Sanz-de la Garza M; Casado M; Garcia NA; Mont L; Sitges M; Knöll R; Buyandelger B; Campuzano O; Diez-Juan A; Brugada R
    Hum Mol Genet; 2016 Sep; 25(17):3676-3688. PubMed ID: 27412010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of an arrhythmogenic right ventricular cardiomyopathy derived iPSC cell line (USFi004-A) carrying a heterozygous mutation in PKP2 (c.1799delA).
    Yang J; Samal E; Burgos Angulo M; Bertalovitz A; McDonald TV
    Stem Cell Res; 2021 Jul; 54():102398. PubMed ID: 34034221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Dalal D; James C; Devanagondi R; Tichnell C; Tucker A; Prakasa K; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    J Am Coll Cardiol; 2006 Oct; 48(7):1416-24. PubMed ID: 17010805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Truncating plakophilin-2 mutations in arrhythmogenic cardiomyopathy are associated with protein haploinsufficiency in both myocardium and epidermis.
    Rasmussen TB; Nissen PH; Palmfeldt J; Gehmlich K; Dalager S; Jensen UB; Kim WY; Heickendorff L; Mølgaard H; Jensen HK; Baandrup UT; Bross P; Mogensen J
    Circ Cardiovasc Genet; 2014 Jun; 7(3):230-40. PubMed ID: 24704780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489 + 1G > A mutation.
    Zhou D; Sun Y; Shen J; Su J; Gong T; Jiang C; Liang P
    Stem Cell Res; 2020 Oct; 48():101965. PubMed ID: 32916635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.